JP Patent

JP5449351B2 — 自己免疫障害および炎症性障害の処置において有用な置換型１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドル−３−イル）酢酸誘導体

Assigned to アリーナ ファーマシューティカルズ， インコーポレイテッド · Expires 2014-03-19 · 12y expired

What this patent protects

Patent listed against Velsipity.

Drugs covered by this patent

Patent Metadata

Patent number
JP5449351B2
Jurisdiction
JP
Classification
—
Expires
2014-03-19
Drug substance claim
No
Drug product claim
No
Assignee
アリーナ ファーマシューティカルズ， インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.